Investing
1379 Articles
Some companies have handed investors a bigger paycheck every single year for more than six decades, surviving every recession and…
Fifty-plus years of unbroken dividend raises sounds like a floor, but not every Dividend King deserves a permanent seat in…
Medicare's IRMAA surcharge punishes a single dollar of overage with a full bracket jump and no phase-in, yet some retirees…
Rolling $880,000 into a self-directed IRA sounds like a clean break from the 9-to-5, but generating $5,200 a month from…
Two healthcare giants, two very different dividend bets: one built on six decades of unbroken raises and a fortress balance…
Four dividend giants from energy and pharma quietly generate the bulk of HDV's income, but their balance sheets and payout…
RAS mutations fuel nearly a third of all cancers, and one biotech has quietly built the deepest late-stage pipeline targeting…
High-yield ETFs built purely on yield rankings carry a hidden flaw that only shows up when it's too late, and…
Johnson & Johnson has surged more than 50% in a year and now sits within striking distance of its 52-week…
Legend Biotech just posted a quarter that flipped a key narrative for LEGN shareholders, but with a CEO transition underway…
Intuitive Surgical is down more than 30% this year, and one investor keeps buying anyway, convinced that a once-per-decade hardware…
Pulling $54,000 a year from a $950,000 rollover IRA sounds like a math problem, but the real trap is hidden…
Four stocks built on investment-grade balance sheets and decades of payout discipline could quietly generate thousands in annual passive income…
Healthcare just posted the best three-month run of any S&P 500 sector, yet two of the three biggest pharma names…
Retiring on dividends at 60 sounds straightforward until you realize the yield tier you choose today could mean the difference…
Our top personal finance-related articles today. Your wallet will thank you later.